Dataset Information


Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein.

ABSTRACT: We previously reported that dietary genistein inhibits mammary tumor growth and metastasis of the highly metastatic MDA-MB-435 cancer cells in immunocompromised mice. The purpose herein was to characterize the role of the novel oncogenic microRNA (miRNA) miR-155 in the anticancer effects of genistein in metastatic breast cancer. The effect of genistein was determined on breast cancer cell viability, apoptosis, and expression of miR-155 and its targets. At low physiologically relevant concentrations, genistein inhibits cell viability and induces apoptosis in metastatic MDA-MB-435 and Hs578t breast cancer cells, without affecting the viability of nonmetastatic MCF-7 breast cancer cells. In parallel with reduced cell viability, miR-155 is downregulated, whereas proapoptotic and anticell proliferative miR-155 targets FOXO3, PTEN, casein kinase, and p27 are upregulated in MDA-MB-435 and Hs578t cells in response to genistein treatment. However, miR-155 levels remain unchanged in response to genistein in the MCF-7 cells. Ectopic expression of miR-155 in MDA-MB-435 and Hs578t cells decreases the effects of genistein on cell viability and abrogates the effects of genistein on apoptosis and expression of proapoptotic genes. Therefore, genistein-mediated downregulation of miR-155 contributes to the anticancer effects of genistein in metastatic breast cancer.

PROVIDER: S-EPMC4936403 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2009-01-01 | S-EPMC2754225 | BioStudies
2011-01-01 | S-EPMC3278899 | BioStudies
1000-01-01 | S-EPMC3339933 | BioStudies
2008-01-01 | S-EPMC2754227 | BioStudies
2007-01-01 | S-EPMC2360449 | BioStudies
2007-01-01 | S-EPMC2246172 | BioStudies
2007-01-01 | S-EPMC2214901 | BioStudies
2019-01-01 | S-EPMC6611796 | BioStudies
2012-01-01 | S-EPMC3492316 | BioStudies
1000-01-01 | S-EPMC4119069 | BioStudies